Related Experiment Videos
Parkinson's disease. Cognitive changes in relation to treatment response
Brain : a Journal of Neurology
|February 1, 1987
Summary
Parkinson's disease patients show cognitive deficits, particularly in frontal lobe functions. Only those with a poor treatment response exhibited impairments across all tested cognitive tasks, suggesting disease severity impacts cognition.
Area of Science:
- Neuroscience
- Neurology
- Cognitive Psychology
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder affecting motor function.
- Previous research linked PD to impairments in frontal lobe functions.
- Dopaminergic system dysfunction is implicated in PD pathophysiology.
Purpose of the Study:
- To investigate cognitive performance across different Parkinson's disease patient groups based on treatment response.
- To compare cognitive functions, particularly frontal lobe abilities, between PD patients and healthy controls.
- To explore the relationship between disease severity and cognitive deficits in Parkinson's disease.
Main Methods:
- Five groups were studied: healthy controls and four Parkinson's disease groups (No Treatment, Good Response, Fluctuations/Dyskinesias, Poor Response).
- Neuropsychological tests assessed frontal lobe functions and psychomotor abilities.
- Further cognitive domains including attention, memory, and visuospatial functions were evaluated.
Main Results:
- All Parkinson's disease groups showed deficits in psychomotor and some frontal lobe tests compared to controls.
- Only the Poor Response group demonstrated impairments across all tested tasks.
- No significant deficits were found in attention, memory, or visuospatial functions in any PD group.
Conclusions:
- Cognitive deficits in Parkinson's disease are not uniform and appear related to disease severity and treatment response.
- The Poor Response group's widespread cognitive impairment may reflect more advanced nigrostriatal and mesocortical dopaminergic pathway involvement.
- Further research is needed to elucidate the precise mechanisms linking dopaminergic dysfunction to specific cognitive profiles in Parkinson's disease.